Aptevo Therapeutics Inc (NASDAQ:APVO)
| 0.185 Delayed Data As of 3:45pm ET |  -0.005 / -2.63%Today’s Change | 0.15 Today|||52-Week Range 7.20 | -92.03% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 33.6M | 36.4M | 14.7M | 23.1M | |
| Cost of Goods Sold | 14.0M | 20.8M | 2.7M | 8.8M | ||
| Depreciation And Amortization | 2.9M | 3.4M | 2.3M | 2.4M | ||
| Operating Expenses | Gross Income | 16.7M | 12.3M | 9.6M | 11.9M | |
| General Expenses | 94.3M | 68.2M | 63.6M | 63.5M | ||
| Research And Development | 51.2M | 29.5M | 29.0M | 35.4M | ||
| Total Operating Expenses | 111.2M | 92.4M | 68.6M | 74.7M | ||
| Non-Operating Expenses | Operating Income | -77.6M | -55.9M | -53.9M | -51.7M | |
| Extraordinary Charge | 0.00 | -71.0M | 0.00 | 0.00 | ||
| Other Expenses | -237.0K | -791.0K | -1.9M | -2.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -77.8M | -127.8M | -55.9M | -53.7M | |
| Income Taxes | -18.5M | -15.3M | -23.3M | 0.00 | ||
| Discontinued Operations | 0.00 | 0.00 | -13.1M | 0.00 | ||
| Extraordinary Items | 0.00 | 0.00 | 52.7M | 0.00 | ||
| Net Income | -59.3M | -112.4M | -45.7M | -53.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 20.2M | 20.2M | 21.3M | 22.5M | |
| Shares To Calculate EPS Diluted | 20.2M | 20.2M | 21.3M | 22.5M | ||
| Earnings Per Share | EPS | -$2.93 | -$5.55 | $0.33 | -$2.39 | |
| EPS Diluted | -$2.93 | -$5.55 | -$2.14 | -$2.39 | ||
